全文获取类型
收费全文 | 95982篇 |
免费 | 7317篇 |
国内免费 | 3831篇 |
专业分类
耳鼻咽喉 | 1993篇 |
儿科学 | 472篇 |
妇产科学 | 2804篇 |
基础医学 | 5803篇 |
口腔科学 | 549篇 |
临床医学 | 10726篇 |
内科学 | 5260篇 |
皮肤病学 | 353篇 |
神经病学 | 684篇 |
特种医学 | 6456篇 |
外国民族医学 | 52篇 |
外科学 | 19455篇 |
综合类 | 15777篇 |
预防医学 | 3134篇 |
眼科学 | 241篇 |
药学 | 4552篇 |
14篇 | |
中国医学 | 492篇 |
肿瘤学 | 28313篇 |
出版年
2024年 | 85篇 |
2023年 | 967篇 |
2022年 | 2087篇 |
2021年 | 2725篇 |
2020年 | 2748篇 |
2019年 | 2135篇 |
2018年 | 1976篇 |
2017年 | 2603篇 |
2016年 | 2918篇 |
2015年 | 2730篇 |
2014年 | 5971篇 |
2013年 | 5229篇 |
2012年 | 6316篇 |
2011年 | 6982篇 |
2010年 | 5911篇 |
2009年 | 5971篇 |
2008年 | 5997篇 |
2007年 | 6349篇 |
2006年 | 5772篇 |
2005年 | 5334篇 |
2004年 | 4224篇 |
2003年 | 3646篇 |
2002年 | 3116篇 |
2001年 | 2978篇 |
2000年 | 2456篇 |
1999年 | 1856篇 |
1998年 | 1563篇 |
1997年 | 1385篇 |
1996年 | 802篇 |
1995年 | 795篇 |
1994年 | 701篇 |
1993年 | 412篇 |
1992年 | 356篇 |
1991年 | 292篇 |
1990年 | 249篇 |
1989年 | 251篇 |
1988年 | 219篇 |
1987年 | 187篇 |
1986年 | 157篇 |
1985年 | 166篇 |
1984年 | 90篇 |
1983年 | 51篇 |
1982年 | 91篇 |
1981年 | 83篇 |
1980年 | 73篇 |
1979年 | 43篇 |
1978年 | 32篇 |
1977年 | 19篇 |
1976年 | 12篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的分析江苏省启东市1972—2016年胃癌死亡流行特征。方法收集启东市1972—2016年恶性肿瘤死亡登记数据库及历年人口资料, 计算死亡率、中国人口标化率(中标率)、世界人口标化率(世标率)、35~64岁截缩率、0~74岁累积死亡率、累积死亡风险、变化百分比、死亡率年均变化百分比。结果 1972—2016年启东市胃癌死亡例数为15 863例, 占全部恶性肿瘤死亡例数的16.04%, 胃癌死亡率为31.37/10万, 中标率为12.97/10万, 世标率为21.39/10万, 35~64岁截缩死亡率为28.86/10万, 0~74岁累积死亡率为2.54%, 胃癌死亡累积风险为2.51%。男性死亡10 114例, 男性死亡率、中标率、世标率分别为40.53/10万、17.98/10万和30.13/10万;女性死亡5 749例, 女性死亡率、中标率、世标率分别为22.45/10万、8.52/10万和13.92/10万。25岁以下各年龄组的死亡率<1/10万, 死亡率随年龄的增长而升高, 50~岁组达到并超过人群的平均死亡率水平, 80~岁组达到死亡高峰。1972—2016年间胃癌死... 相似文献
2.
3.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2022,34(7):472-479
AimsTreatment decisions for older patients with breast cancer are complex and evidence is largely extrapolated from younger populations. Frailty and comorbidity need to be considered. We studied the baseline characteristics and treatment decisions in older patients in Christchurch with breast cancer and assessed survival outcomes and prognostic/discriminatory performance of several tools.Materials and methodsWe searched the Canterbury Breast Cancer Registry and identified patients aged 70 years or older at diagnosis with invasive, non-metastatic breast cancer between 1 June 2009 and 30 June 2015. We retrieved demographics, treatment and outcome information. Overall survival and breast cancer-specific survival were estimated. Tools analysing performance status and comorbidity were assessed for their prognostic and discriminatory power.ResultsIn total, 440 patients were identified. Primary surgery was carried out for 362 patients (82.3%): breast-conserving surgery in 114 (of whom 88.6% received radiation therapy); mastectomy in 248 (of whom 24.6% received radiation). Hormone therapy was given for 265 (71.1%) patients with oestrogen receptor-positive cancers. Two hundred and seventy-four (62.3%) patients received full standard treatment, which was associated with significantly improved 5-year survival and 5-year breast cancer-specific survival. The median estimated overall survival was 8.2 years (95% confidence interval 7.3–9.1 years). Of those who died, 71.3% of deaths were due to causes other than breast cancer or unknown causes. The comorbidity-adjusted life expectancy (CALE) showed partial prognostic accuracy. CALE, Charlson and Eastern Cooperative Oncology Group tools all showed discriminatory value.ConclusionIn this population-based series of older patients with breast cancer, showing high levels of primary and adjuvant treatment, patients were more likely to die of causes other than breast cancer. Performance status and comorbidity tools showed prognostic and discriminatory potential in this population supporting their use in treatment decision making. CALE showed the most potential to improve treatment decisions but requires validation in this population to improve prognostic accuracy. 相似文献
4.
5.
《Cirugía espa?ola》2023,101(5):325-332
IntroductionIn our institution, the study of selective sentinel node biopsy (SLNB) is performed intraoperatively. The main objective of our study is to know the proportion of patients who benefits from the waiting of the results of SLNB.MethodsA retrospective analysis of patients operated on our center between January 1 st, 2018 and June 30, 2019 was carried out. We included women diagnosed with T1–T2 tumors, treated by lumpectomy and SLNB studied using OSNA method.ResultsOur study included 149 women. There were not statistically significant differences in terms of demographic data between the group treated with axillary lymph node dissection (ALND) and exclusively SLNB group. After analysis of SLN intraoperatively, there were performed 18 axillary lymphadenectomies. Only in six of these 18 cases, three or more sentinel nodes were founded. The location of the tumor, the presence of lymphovascular permeation and the total tumor load (TTL) showed statistically significant differences between groups. Only the TTL was established as the independent factor of the need for ALND.ConclusionsObtaining a deferred result of the SLNB allowed reducing the time of anesthesia and occupation of the operating room, since in a high percentage of cases an additional procedure is not performed. 相似文献
6.
7.
8.
9.
10.
Tomoe Koizumi PhD Yodo Sugishita MD PhD Yuki Suzuki-Takahashi MD PhD Kazuko Nara MA Tomoko Miyagawa MA Misako Nakajima MA Kouhei Sugimoto MD PhD Manabu Futamura MD PhD Tatsuro Furui MD PhD Yasushi Takai MD PhD Hiroshi Matsumoto MD PhD Hideko Yamauchi MD Shinji Ohno MD PhD Akemi Kataoka MD PhD Kiyotaka Kawai MD PhD Eisuke Fukuma MD PhD Hiroko Nogi MD PhD Koichiro Tsugawa MD PhD Nao Suzuki MD PhD 《Cancer》2023,129(16):2568-2580